$3.59 BillionThe market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.
-Total revenue in the last quarter.
-Net income is all revenues minus all expenses including taxes and interest in the last quarter.
$-0.72Earnings per share is the amount of net income that is attributed to each single share outstanding.
$1.0 (4.57%)Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).
-30.38xThe price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.
-Earnings before interest expenses and taxes in the last quarter.
7,000The number of full time employees.
The Chemours Co. is a holding company, which engages in the provision of performance chemicals. It operates through the following segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment produces titanium dioxide. The Fluoroproducts segment supplies refrigerants and industrial fluoropolymer resins. The Chemical Solutions segment provides chemicals used in gold production, oil refining, agriculture, and industrial polymers. The firm offers refrigerants, industrial fluoropolymer resins, sodium cyanide, performance chemicals and intermediates, and titanium dioxide pigments to the plastics and coatings, refrigeration and air conditioning, general industrial, electronics, mining, and oil refining markets. The company was founded on February 18, 2014 and is headquartered in Wilmington, Delaware.
Wall Street brokerages forecast that The Chemours Company (NYSE:CC) will report $0.32 earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Three analysts have m...The Olympia Report, 5 days ago
The Chemours Company (NYSE:CC) – Truist Securiti lifted their Q3 2020 earnings per share (EPS) estimates for The Chemours in a research report issued on Monday, October 19th. Truist Securiti analys...Zolmax News, 6 days ago
The Chemours Company (NYSE:CC) – Equities research analysts at Truist Securiti raised their Q3 2020 EPS estimates for The Chemours in a report issued on Monday, October 19th. Truist Securiti analys...Daily Political, 8 days ago